Yarrow Bioscience YARW
NASDAQ YARW
$37.93 -2.67 (-6.58%)
At close: Aug 20, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Capital Expenditures (2017 - 2021)

Yarrow Bioscience's (YARW) quarterly Capital Expenditures came in at $376000.0 in Q4 2021, up 210.26% on a QoQ basis from -$341000.0 in Q3 2021.

Yarrow Bioscience (YARW) Capital Expenditures (2017 - 2021) Analysis & Trends

Yarrow Bioscience (YARW) has 5 years of Capital Expenditures data on file, last reported at $376000.0 in Q4 2021.

  • Quarterly Capital Expenditures changed N/A year-over-year to $376000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $376000.0 (up 130.9% YoY) and the FY2024 annual result came in at $117000.0, changed N/A from the prior year.
  • Capital Expenditures climbed to $376000.0 in Q4 2021, from -$341000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $934000.0 in Q4 2019 to a low of -$472000.0 in Q2 2021.
  • A 5-year average of $55400.0 and a median of $71000.0 in 2020 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2018 — Capital Expenditures jumped 228.79% — and 2021, when it slumped 1061.9%.
  • Tracing YARW's Capital Expenditures over 5 years: stood at -$66000.0 in 2017, then surged by 780.3% to $449000.0 in 2018, then soared by 108.02% to $934000.0 in 2019, then plunged by 92.4% to $71000.0 in 2020, then surged by 429.58% to $376000.0 in 2021.
  • The last three Capital Expenditures figures came in at $376000.0 (Q4 2021), -$341000.0 (Q3 2021), and -$472000.0 (Q2 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 25.02 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 34.68 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 6.26 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 251.02 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -73.57 Mn
10 Yarrow Bioscience 32.54 Mn 9.62 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 376,000.00
Dec 31, 2021 376,000.00
Sep 30, 2021 -341,000.00
Sep 30, 2021 -341,000.00
Jun 30, 2021 -472,000.00
Jun 30, 2021 -472,000.00
Mar 31, 2021 -404,000.00
Mar 31, 2021 -404,000.00
Jun 30, 2020 71,000.00
Jun 30, 2020 71,000.00
Mar 31, 2020 42,000.00
Mar 31, 2020 42,000.00
Dec 31, 2019 934,000.00
Dec 31, 2019 934,000.00
Sep 30, 2019 -330,000.00
Sep 30, 2019 -330,000.00
Jun 30, 2019 316,000.00
Jun 30, 2019 316,000.00
Mar 31, 2019 138,000.00
Mar 31, 2019 138,000.00